Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1977 Dec;74(12):5711–5715. doi: 10.1073/pnas.74.12.5711

Unusual pulmonary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with endoperoxides and other prostanoids.

A L Hyman, B M Chapnick, P J Kadowitz, W E Lands, C G Crawford, J Fried, J Barton
PMCID: PMC431863  PMID: 414226

Abstract

Microsomes from stomach fundus and blood vessels transform the endoperoxide, PGH2, into a newly discovered unstable substance, PGI2, that relaxes arterial strips and inhibits platelet aggregation. 13,14-Dehydro-PGI2 methyl ester, a newly synthesized, stable PGI2 analog, was found to have potent vasodilator activity in the feline and simian pulmonary vascular bed. The PGI2 analog decreased lobar arterial perfusion pressure in the intact cat and monkey. Because pulmonary blood flow was held constant and left atrial pressure was unchanged, the decrease in perfusion pressure reflects a decrease in pulmonary vascular resistance. The dilator response was unusual in that it persisted for 10-12 min, whereas the response to PGE1, the only other vasodilator prostaglandin in the mature animal, persisted for only 1-2 min. The dilator response to the PGI2 analog was enhanced when pulmonary vascular resistance was increased. This substance had less effect on cardiac output and aortic pressure than PGE1, whereas it was a more potent pulmonary vasodilator. These data demonstrate that prostacyclin-like substances possess novel vasodilator activity in the pulmonary circulation and suggest a therapeutic use in the treatment of pulmonary hypertensive diseases.

Full text

PDF
5711

Images in this article

5712Image
on p.5712
5713Image
on p.5713
5713Image
on p.5713
5714Image
on p.5714
5714Image
on p.5714

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anggård E., Samuelsson B. Biosynthesis of prostaglandins from arachidonic acid in guinea pig lung. Prostaglandins and related factors. 38. J Biol Chem. 1965 Sep;240(9):3518–3521. [PubMed] [Google Scholar]
  2. Bunting S., Gryglewski R., Moncada S., Vane J. R. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins. 1976 Dec;12(6):897–913. doi: 10.1016/0090-6980(76)90125-8. [DOI] [PubMed] [Google Scholar]
  3. Fried J., Barton J. Synthesis of 13,14-dehydroprostacyclin methyl ester: a potent inhibitor of platelet aggregation. Proc Natl Acad Sci U S A. 1977 Jun;74(6):2199–2203. doi: 10.1073/pnas.74.6.2199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gryglewski R. J., Bunting S., Moncada S., Flower R. J., Vane J. R. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins. 1976 Nov;12(5):685–713. doi: 10.1016/0090-6980(76)90047-2. [DOI] [PubMed] [Google Scholar]
  5. Hamberg M., Samuelsson B. Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proc Natl Acad Sci U S A. 1973 Mar;70(3):899–903. doi: 10.1073/pnas.70.3.899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hamberg M., Samuelsson B. Prostaglandin endoperoxides. VII. Novel transformations of arachidonic acid in guinea pig lung. Biochem Biophys Res Commun. 1974 Dec 11;61(3):942–949. doi: 10.1016/0006-291x(74)90246-0. [DOI] [PubMed] [Google Scholar]
  7. Hamberg M., Samuelsson B. Prostaglandin endoperoxides. VII. Novel transformations of arachidonic acid in guinea pig lung. Biochem Biophys Res Commun. 1974 Dec 11;61(3):942–949. doi: 10.1016/0006-291x(74)90246-0. [DOI] [PubMed] [Google Scholar]
  8. Hamberg M., Svensson J., Wakabayashi T., Samuelsson B. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc Natl Acad Sci U S A. 1974 Feb;71(2):345–349. doi: 10.1073/pnas.71.2.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hyman A. L. Effects of large increases in pulmonary blood flow on pulmonary venous pressure. J Appl Physiol. 1969 Aug;27(2):179–185. doi: 10.1152/jappl.1969.27.2.179. [DOI] [PubMed] [Google Scholar]
  10. Hyman A. L., Kadowitz P. J. Effects of alveolar and perfusion hypoxia and hypercapnia on pulmonary vascular resistance in the lamb. Am J Physiol. 1975 Feb;228(2):397–403. doi: 10.1152/ajplegacy.1975.228.2.397. [DOI] [PubMed] [Google Scholar]
  11. Hyman A. L., Knight D. S., Joiner P. D., Kadowitz P. J. Bronchopulmonary arterial shunting without anatomic anastomosis in the dog. Circ Res. 1975 Sep;37(3):285–298. doi: 10.1161/01.res.37.3.285. [DOI] [PubMed] [Google Scholar]
  12. Hyman A. L., Woolverton W. C., Pennington D. G., Jaques W. E. Pulmonary vascular responses to adenosine diphosphate. J Pharmacol Exp Ther. 1971 Sep;178(3):549–561. [PubMed] [Google Scholar]
  13. Kadowitz P. J., Gruetter C. A., McNamara D. B., Gorman R. R., Spannhake E. W., Hyman A. L. Comparative effects of endoperoxide PGH2 and an analog on the pulmonary vascular bed. J Appl Physiol Respir Environ Exerc Physiol. 1977 Jun;42(6):953–958. doi: 10.1152/jappl.1977.42.6.953. [DOI] [PubMed] [Google Scholar]
  14. Kadowitz P. J., Hyman A. L. Influence of a prostaglandin endoperoxide analogue on the canine pulmonary vascular bed. Circ Res. 1977 Mar;40(3):282–287. doi: 10.1161/01.res.40.3.282. [DOI] [PubMed] [Google Scholar]
  15. Kadowitz P. J., Joiner P. D., Hyman A. L. Effects of prostaglandins E1 and F2a on the swine pulmonary circulation. Proc Soc Exp Biol Med. 1974 Jan;145(1):53–58. doi: 10.3181/00379727-145-37746. [DOI] [PubMed] [Google Scholar]
  16. Moncada S., Gryglewski R., Bunting S., Vane J. R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976 Oct 21;263(5579):663–665. doi: 10.1038/263663a0. [DOI] [PubMed] [Google Scholar]
  17. Nugteren D. H., Hazelhof E. Isolation and properties of intermediates in prostaglandin biosynthesis. Biochim Biophys Acta. 1973 Dec 20;326(3):448–461. doi: 10.1016/0005-2760(73)90145-8. [DOI] [PubMed] [Google Scholar]
  18. Pace-Asciak C. Polyhydroxy cyclic ethers formed from tritiated arachidonic acid by acetone powders of sheep seminal vesicles. Biochemistry. 1971 Sep 28;10(20):3664–3669. doi: 10.1021/bi00796a005. [DOI] [PubMed] [Google Scholar]
  19. Pace-Asciak C., Wolfe L. S. A novel prostaglandin derivative formed from arachidonic acid by rat stomach homogenates. Biochemistry. 1971 Sep 28;10(20):3657–3664. doi: 10.1021/bi00796a004. [DOI] [PubMed] [Google Scholar]
  20. Smith J. B., Ingerman C., Kocsis J. J., Silver M. J. Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction. J Clin Invest. 1974 May;53(5):1468–1472. doi: 10.1172/JCI107695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Whittaker N., Bunting S., Salmon J., Moncada S., Vane J. R., Johnson R. A., Morton D. R., Kinner J. H., Gorman R. R., McGuire J. C. The chemical structure of prostaglandin X (prostacyclin). Prostaglandins. 1976 Dec;12(6):915–928. doi: 10.1016/0090-6980(76)90126-x. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES